Trilogy Capital Portfolio holdings
Top Buys
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$17.8M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$16.1M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$6.96M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.3M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$4.79M |
Sector Composition
| 1 | Consumer Staples | 0.79% |
| 2 | Consumer Discretionary | 0.59% |
| 3 | Utilities | 0.59% |
| 4 | Technology | 0.45% |
| 5 | Financials | 0.45% |
Similar funds
Trilogy Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Trilogy Capital held 166 positions worth $840M, up 13% from $743M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Trilogy Capital deployed $28.6M of net new capital in Q1 2019, opening 35 new positions and adding to 31 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Growth ETF: 179,055 shares worth $6.66M.
By sector, the portfolio is most concentrated in Consumer Staples at 0.79% of assets, down from 1% a quarter earlier, followed by Consumer Discretionary and Utilities.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $17.8M trimmed.
- Trilogy Capital's largest Q1 2019 buy was State Street SPDR Portfolio S&P 500 Growth ETF: 179,055 shares worth $6.66M.
- Trilogy Capital added most to iShares MSCI USA Quality Factor ETF in Q1 2019, an estimated $26.1M increase.
- Trilogy Capital's biggest Q1 2019 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $17.8M.
- Trilogy Capital fully exited Invesco FTSE RAFI US 1000 ETF in Q1 2019, selling an estimated $2.93M.
- Trilogy Capital's ten largest holdings make up 49% of its $840M portfolio in Q1 2019.
- Trilogy Capital opened 35 new positions and closed 42 in Q1 2019.
- Trilogy Capital's portfolio value rose 13% quarter-over-quarter to $840M.
Based on Trilogy Capital's 13F filing for Q1 2019, filed 17 Apr 2019.